Impact of pharmacist-led interventions on medication-related problems among patients treated for cancer: A systematic review and meta-analysis of randomized …

AM Fentie, SA Huluka, GT Gebremariam… - Research in Social and …, 2024 - Elsevier
Abstract Background Medication-related problems (MRPs) continue to impose a voluminous
health impact, particularly among patients on anti-cancer therapy, due to the nature and …

Creating a blueprint of well-being in oncology: an approach for addressing burnout from ASCO's clinician well-being taskforce

FJ Hlubocky, TD Shanafelt, AL Back… - American Society of …, 2021 - ascopubs.org
Optimizing the well-being of the oncology clinician has never been more important. Well-
being is a critical priority for the cancer organization because burnout adversely impacts the …

[HTML][HTML] Clinical Pharmacist-Led Interventions for Improving Breast Cancer Management—A Scoping Review

R Staynova, E Gavazova, D Kafalova - Current Oncology, 2024 - mdpi.com
Breast cancer is the leading cause of cancer-related death in women worldwide and the fifth
most common cause of cancer death overall. Most women with breast cancer have a good …

[HTML][HTML] Optimizing medication safety with oral antitumor therapy: A methodological approach for the real-world implementation of the AMBORA Competence and …

L Cuba, K Schlichtig, P Dürr, EC Inwald, MF Fromm… - Healthcare, 2023 - mdpi.com
Generating evidence for the efficacy of an intervention is not sufficient to guarantee its
implementation in real-world settings. The randomized AMBORA trial (Medication Safety …

Assessment of attrition and retention factors in the oncology pharmacy workforce: results of the oncology pharmacy workforce survey

KV Rao, AM Gulbis… - Journal of the American …, 2022 - Wiley Online Library
Introduction Hospital departments of pharmacy are experiencing significant challenges in
the recruitment and retention of trained hematology‐oncology pharmacists. The reasons for …

[HTML][HTML] Assessment of patient perceptions of counselling on oral antineoplastic agents by a dedicated cancer services pharmacist in an outpatient cancer clinic

L McNabb, E Metrot, M Ferrington, B Sunderland… - PloS one, 2024 - journals.plos.org
Background Oral antineoplastic agents have caused a paradigm shift in cancer treatment,
however, they produce many unique challenges. Although oral antineoplastics can have …

Clinical and economic impact of oncology-trained pharmacist integration in an ambulatory cancer clinic

A Mull, C Hawkins, A Punke… - Journal of Oncology …, 2024 - journals.sagepub.com
Introduction Outpatient oncology practice is a growing area of opportunity for pharmacists to
provide clinical services and evidence-based care. Methods This single-center …

Oncology pharmacy practice in the United States: Results of a comprehensive, nationwide survey

SP Griffin, JR Signorelli, A Lasko… - Journal of Oncology …, 2024 - journals.sagepub.com
Introduction: This study was designed to describe the landscape of oncology pharmacy
practice at patient facing institutional healthcare organizations throughout the United States …

A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and …

L Cuba, P Dürr, K Gessner, B Häcker, R Fietkau… - JCO Oncology …, 2024 - ascopubs.org
PURPOSE Implementation science endeavors to facilitate the translation of evidence-based
research into clinical routine. The clinical pharmacological/pharmaceutical care program …

Our dual responsibility of improving quality and questioning the metrics: Reflections on 30-day readmission rate as a quality indicator

SP Huepenbecker, LA Meyer - Gynecologic …, 2022 - gynecologiconcology-online.net
Unplanned readmissions are increasingly important to both gynecologic oncology patients
and hospitals as our healthcare system has focused on improving quality of care. This focus …